Ekso Bionics Holdings, Inc. (EKSO)

Designs and manufactures exoskeletons for medical and industrial use.

EKSO Stock Quote

Company Report

Ekso Bionics Holdings, Inc., headquartered in Richmond, California, specializes in the design, development, sale, and rental of exoskeleton products worldwide. The company operates through two distinct segments: EksoHealth and EksoWorks. The EksoHealth segment focuses on designing and manufacturing exoskeletons tailored for medical applications, catering to the needs of patients recovering from conditions such as acquired brain injury, stroke, and spinal cord injury. These innovative devices, including the EksoNR and EksoUE, assist physical therapists and physicians in enhancing rehabilitation outcomes by providing targeted support and assistance.

In contrast, the EksoWorks segment is dedicated to developing exoskeleton devices that enable able-bodied individuals to perform physically demanding tasks over extended periods. These exoskeletons are designed to alleviate the strain and fatigue associated with repetitive manual labor, enhancing productivity and reducing the risk of workplace injuries. Ekso Bionics leverages advanced engineering and manufacturing capabilities to deliver cutting-edge solutions that address both medical rehabilitation and industrial needs.

Founded in 2005, Ekso Bionics has continually expanded its technological prowess and market presence through strategic partnerships and collaborations. The company's collaboration with Lockheed Martin Corporation exemplifies its commitment to integrating exoskeleton technology across diverse sectors, further solidifying its position as a leader in the field of wearable robotics. With a focus on innovation and improving human mobility, Ekso Bionics remains at the forefront of transforming healthcare and industrial work environments through advanced exoskeleton solutions.

EKSO EPS Chart

EKSO Revenue Chart

Stock Research

BRBS GPCR ORGN AEE SMTC CHCO DXR

EKSO Chart

View interactive chart for EKSO

EKSO Profile

EKSO News

Analyst Ratings